Search results for "Rigaku Analytical Devices"

One test that can expedite NSCLC treatment selection decisions. The Oncomine Dx Target Test is the first targeted NGS-based in vitro diagnostic test for NSCLC, simultaneously delivering multiple biomarker results from one sample within four days and helping inform treatment decisions.

Extend your LC column lifetime while maintaining chromatographic performance.

Researchers are uncovering previously unknown sources of PFAS using robotic sample preparation and high-resolution mass spectrometry

High-end titrator for potentiometric and volumetric Karl Fischer titration with two measuring interfaces and Dosino dosing units.

New and expanded facilities provide local expertise, advanced technologies and tailored support for biopharma innovators throughout the region

Includes 10 ml/min pumps, multi-wavelength (UV/Vis) detection, buffer blending options, for rapid pH scouting during the purification of proteins, peptides, and nucleic acids

Celebration marks 70 years since the launch of the world’s first commercially available blood gas analyzer

Don Whitley Scientific reaches milestone showing unwavering commitment to microbiology

Learn how BioApp Solutions enhances liquid handling efficiency with INTEGRA Biosciences' pipettes

Mobile robotics are transforming laboratory operations by addressing staffing shortages, streamlining workflows, and ensuring 24/7 efficiency in clinical settings

In-house cannabis and hemp testing technology

Tecan has reinvented automation with the Fluent Laboratory Automation Workstation, a unique instrumentation concept built around the application-specific needs of your laboratory. Fluent breaks new ground, delivering more capacity and increased speed. It provides superior precision, throughput and walkaway time, making it easier to get more done, more confidently.

After decades of experience in precise stack gas measurement, HORIBA's brand new ENDA series represents the ultimate stack gas analyzer.

Dr. Mimi Roy's commitment to scientific excellence and her work developing gene therapies for rare diseases